Yeah, so, I was just Medicine Hat last week and the plants running very nicely, its looks like a brand-new plan. So, this was not a normal turnaround, it was 1/10 of the man-hours of new build. And about a $100 million, which is about 1/10 of the new-build as well. So, all of this was completed in just over 60 days. So, an outstanding accomplishment by our team there. We think we're going to get higher rates. It's early days, we are injecting CO2, we think we can inject up to 350 tons a day of CO2, and that, at that rate, we believe we can get over 1,700 tons a day and well over 600,000 tons on an annual basis. And we think this plant now is lined out and going to be real reliable to the end of the decade, and we've tied up gas, 40% of our gas requirements have really attractive prices. So, this dual on the Prairie will continue to generate significant EBITDA and cash flow for the company. As far as the second plant, we continue to progress that. We've got a bit of a stumbling block on getting the product out of Medicine Hat, to the West Coast. We wouldn't move forward with the second project until he had some sort of certainty on rail, i.e., how is going to cost us over a period of time, team's working on that issue and we hope to resolve it in the coming months and we're progressing that project in a third plant in Geismar at the same time, spending some millions of dollars on both maybe do a feed on one or both sometime next year and look to be in FID position for one or both at the end of next year. So, I think for the next couple of years as far as capital, we don't have any significant capital spend beyond what we're completing in Geismar and if we sanction one or both of those projects the capital spending would ramp up somewhere towards the end of 2017.